Streetbeat News

Stock Prices

WMS

Advanced Drainage Systems has revised its FY24 net sales outlook from $2.6B-$2.8B to $2.7B-$2.8B.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 10:45 am

BWA

BorgWarner has revised its FY23 adjusted EPS guidance from $3.50-$3.85 to $3.60-$3.80, which is below the estimated $3.92.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 10:40 am

MRNA

Moderna has projected its FY24 revenue to be around $4 billion and expects to return to growth in 2025.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 10:39 am

VNT

Vontier Corp has provided its Q4 and FY23 outlook, expecting a decrease in total sales and adjusted EPS. For Q4, total sales are expected to be down low-double digits compared to the $801.85M estimate, with an adjusted EPS of $0.75-$0.79 versus the $0.82 estimate. For FY23, total sales are expected to be down low-single digits compared to the $3.09B estimate, with an adjusted EPS of $2.83-$2.87, compared to the prior range of $2.79-$2.87 and the $2.85 estimate.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 10:38 am

BWA

BorgWarner has reduced its FY23 revenue guidance from $14.2B-$14.6B to $14.1B-$14.3B, which is below the estimated $14.82B.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 10:38 am

MRNA

Moderna has revised its FY23 product sales forecast to at least $6B, down from the previous range of $6B-$8B. The main factor affecting sales is the U.S. vaccination rates, with the estimate based on trends from fall 2022.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 10:37 am

IMGN

ImmunoGen has reaffirmed its FY23 sales guidance, excluding Elahere sales, to be between $45M-$50M.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 10:33 am

WLKP

Westlake Chemical (NYSE:WLKP) reported Q3 earnings of $0.37 per share, a decrease of 11.9% from the same period last year. The company's quarterly sales were $321.66 million, missing the analyst consensus estimate of $357.02 million by 9.90%. This represents a 22.51% decrease in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 10:33 am

OLIT

OmniLit Acquisition Corp. (OLIT) shares surged 200% in premarket trading after the company announced that its merger with Syntec was approved by shareholders.

Portfolio Pulse from Charles Gross

November 02, 2023 | 10:27 am

SBUX

Starbucks reported better-than-expected Q4 financial results and comparable sales growth, leading to a rise in its share price.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 10:26 am